Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2001The Journal of Urology

Clinical Role of F-18 Fluorodeoxyglucose Positron Emission Tomography for Detection and Management of Renal Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SRShakher RamdaveMonash HealthGTGWYNNE W. THOMASHarry Perkins Institute of Medical ResearchSBSalvatore U. BerlangieriAustin Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ramdave et al. (2001) studied this question.

synapsesocial.com/papers/6a7045bc5d37378ac1dd58afhttps://doi.org/10.1016/s0022-5347(05)65845-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Imaging of Renal Cancer Using Positron Emission Tomography with 2-Deoxy-2-(18F)-Fluoro-D-Glucose: Pilot Animal and Human Studies1991 · 73 citations
  2. 2Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.1996 · 311 citations
  3. 3The Results of Radical Nephrectomy for Renal Cell Carcinoma2016 · 1,160 citations
  4. 4F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer*11999 · 63 citations